News

Sharansky using his ‘Jewish Nobel’ winnings to help those affected by COVID-19

(JTA) When Natan Sharansky learned in December that he would become the eighth Genesis Prize honoree, he decided he would use his $1 million (R18.7 million) prize money to promote issues to which he has devoted his life: human rights and Zionism.

Published

on

MARCY OSTER

That was before the coronavirus crisis.

Now, Sharansky, the former Soviet dissident who has become a prominent leader in Israel, and the Genesis Prize Foundation are announcing that his winnings will instead go to organisations fighting the pandemic and to support the individuals most affected by it in Israel, the United States, and seven other countries. They also announced a new competition to reward Israeli innovations working to stop the pandemic.

The coronavirus is a “new challenge, a new enemy”, Sharansky told the Jewish Telegraphic Agency (JTA). His other interests, he said, “can wait a little bit”.

In Israel, the grants will fund nine organisations working to help the most vulnerable populations affected by the pandemic and advance medical and scientific innovation. Grants will also help isolated and elderly Jews in Rome, Madrid, Paris, Moscow, the United Kingdom, Ukraine, and Belarus. And they will fund research at two universities in New York, and support grants made by a Jewish loan society.

Sharansky, 72, spent nine years in a Soviet prison, half them in solitary confinement, and he kept himself sane by playing chess in his mind. He has been helping Jews around the world during the pandemic by speaking to Jewish schools, groups, and communities about living in isolation.

“Freedom is inside of yourself,” Sharansky told JTA. “If you can fight for the things you really believe, then you are free.”

Last month, Sharansky made a three-minute video offering five tips on living in isolation that has been seen by tens of thousands of people. Prior to talking to JTA on Sunday, he spoke to the Bulgarian Jewish community on a Zoom call. He admitted that two months ago, he didn’t know what Zoom was. Now, he considers himself an expert.

Sharansky, who serves as chairperson of the Institute for the Study of Global Antisemitism and Policy, acknowledged the rise in anti-Semitism brought about by the pandemic. Prior to that, he spent nine years as chairperson of the executive of the Jewish Agency for Israel. He also served in four Israeli governments, holding ministerial positions as head of his Yisael B’Aliyah party, formed to help integrate new immigrants into Israeli society.

The Genesis Prize, known as the “Jewish Nobel”, was started in 2013, and is financed through a permanent $100 million (R1.87 billion) endowment. The annual award honours “extraordinary individuals for their outstanding professional achievement, contribution to humanity, and commitment to Jewish values.” Previous winners of the prize include New England Patriots owner Robert Kraft, former New York City Mayor Michael Bloomberg, and musician Itzhak Perlman. US Supreme Court Justice Ruth Bader Ginsburg received a lifetime achievement award from Genesis in 2018.

The Israeli organisations receiving Sharansky’s Genesis grants offer a variety of services to a wide range of populations. They are:

  • 1221 Assistance for All – an emergency response service in Jerusalem for Jews and non-Jews during the pandemic;
  • The Association of Rape Crisis Centers in Israel, after a 40% increase in domestic-violence calls;
  • Aleh Negev, which supports children with severe disabilities whose schooling has been disrupted;
  • Terem Public Clinic, which provides medical services to the residents of south Tel Aviv, including many asylum seekers and those in the country illegally who don’t have access to health care;
  • Enosh Israeli Mental Health Organisation, which is responding to an increasing number of people requiring mental health services;
  • Migdal Ohr, which supports high-risk Israeli prisoners sent home during the pandemic;
  • Two projects in partnership with the Jewish Agency for Israel: volunteer service at Machon Shlichim working with the elderly and at-risk youth, and funding interest-free loans for Israeli nongovernmental organisations through Ogen; and
  • The Weizmann Institute, which will use the grant to fund research to develop a COVID-19 vaccine.

Grants will also help send volunteers to assist the isolated and elderly members of the Jewish communities affected by COVID-19 in Rome, Madrid, Paris, and Moscow through Moishe House, an international organisation working with young adults; and to assist 130 Hillel student volunteers working with Jewish elderly and homebound in six cities in Ukraine and Belarus. A grant to Jewish Care in the United Kingdom will provide protective equipment to staff working with isolated and impoverished elderly people who are especially vulnerable to the virus.

Grants in the US will fund research at the Columbia University Irving Medical Center to mitigate medical complications of coronavirus; a competition for students at New York University Tandon School of Engineering to solve physical challenges presented by COVID-19; and support for Hebrew Free Loan, a non-profit organisation that is distributing no-interest loans to people in New York who require emergency assistance because of the economic disruption caused by the pandemic.

The Genesis Prize Foundation also announced a special competition in honour of Sharansky that will recognise Israeli companies working to combat COVID-19 and prepare the world for future pandemics. Start-Up Nation Central, a non-profit organisation founded by philanthropist Paul Singer, will run the competition with Genesis to promote the Israeli innovations globally.

Sharansky said he hoped the pandemic would yield positive effects for the world, even as it causes death and devastation.

“I hope there will be much more unity in general of people all around the world,” he said, and that the moment would hopefully increase “our understanding that there are things we can fight and defeat together”.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version